Circulating tumor DNA to predict timing of relapse in mantle cell lymphoma.

被引：3
|
作者：
Roschewski, Mark J.
Melani, Christopher Joseph
Pittaluga, Stefania
Dunleavy, Kieron
Saba, Nakhle S.
Grant, Cliona
Aaron, Joan
Jacob, Allison
Yusko, Erik
Steinberg, Seth M.
Jaffe, Elaine S.
Wiestner, Adrian
Wilson, Wyndham Hopkins
机构：
[1] NCI, Lymphoid Malignancies Branch, Ctr Canc Res, Bethesda, MD 20892 USA
[2] NCI, Ctr Canc Res, Bethesda, MD 20892 USA
[3] Ctr Canc Res, Div Canc Treatment & Diag, Bethesda, MD USA
[4] Tulane Univ Hlth Sci Ctr, New Orleans, LA USA
[5] St James Hosp, Dublin, Ireland
[6] NCI, Bethesda, MD 20892 USA
[7] Adapt Biotechnol, Seattle, WA USA
[8] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.7576
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7576
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Circulating tumor DNA in Hodgkin lymphoma
    Maria Maco
    Kristyna Kupcova
    Vaclav Herman
    Iva Ondeckova
    Tomas Kozak
    Heidi Mocikova
    Ondrej Havranek
    Annals of Hematology, 2022, 101 : 2393 - 2403
  • [42] Circulating tumor DNA in Hodgkin lymphoma
    Maco, Maria
    Kupcova, Kristyna
    Herman, Vaclav
    Ondeckova, Iva
    Kozak, Tomas
    Mocikova, Heidi
    Havranek, Ondrej
    ANNALS OF HEMATOLOGY, 2022, 101 (11) : 2393 - 2403
  • [43] Dose dense, high intensity therapy for mantle cell lymphoma.
    Rizzieri, DA
    Gockerman, JP
    Moore, JO
    DeCastro, C
    Long, GD
    Vredenburgh, JJ
    Niedzwiecki, D
    Edwards, J
    Prosnitz, L
    Gasparetto, C
    Morris, A
    Lassiter, M
    Davis, P
    Chao, NJ
    BLOOD, 2001, 98 (11) : 681A - 682A
  • [44] Correlation of cytogenetic abnormalities with clinical presentation in mantle cell lymphoma.
    Onciu, M
    Schlette, E
    Abruzzo, LV
    Medeiros, LJ
    Lai, R
    MODERN PATHOLOGY, 2001, 14 (01) : 174A - 174A
  • [45] TREATMENT OF RELAPSING OR REFRACTORY MANTLE CELL LYMPHOMA. UNICENTRIC STUDY
    Marc, Sorigue
    Juan-Manuel, Sancho
    Lluis, Virgili
    Miriam, Moreno
    Cristina, Motllo
    Gustavo, Tapia
    Susanna, Gassiot
    Alberto, Pineda
    Jose-Luis, Mate
    Laura, Abril
    Monica, Linares
    Clara, Maluquer
    Edurne, Sarrate
    Ana, Triguero
    Neus, Ruiz-Xiville
    Anna, Torrent
    Susana, Vives
    Christelle, Ferra
    Blanca, Xicoy
    Montserrat, Batlle
    Gladys, Ibarra
    Immaculada, Portal
    Jose-Tomas, Navarro
    Evarist, Feliu
    Josep-Maria, Ribera
    HAEMATOLOGICA, 2016, 101 : 207 - 208
  • [46] Natural history and clinical prognosis of in situ mantle cell lymphoma.
    Kubal, Timothy Edward
    Peker, Deniz
    Sagatys, Elizabeth
    Zhang, Ling
    Naghashpour, Mojdeh
    Moscinski, Lynn
    Sotomayor, Eduardo M.
    Sokol, Lubomir
    Bello, Celeste M.
    Cultrera, Jennifer L.
    Chervenick, Paul A.
    Shah, Bijal D.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [47] Cladribine plus rituximab for the initial treatment of mantle cell lymphoma.
    Pindyck, T.
    Spurgeon, S. E.
    Okada, C. Y.
    Epner, E. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [48] Correlation of cytogenetic abnormalities with clinical presentation in mantle cell lymphoma.
    Onciu, M
    Schlette, E
    Abruzzo, LV
    Medeiros, LJ
    Lai, R
    LABORATORY INVESTIGATION, 2001, 81 (01) : 174A - 174A
  • [49] Analysis of nuclear factor kappa B in mantle cell lymphoma.
    Schrader, C
    Klapper, W
    Janssen, D
    Riis, P
    Meusers, P
    Brittinger, G
    Siebmann, JU
    Kneba, M
    Parwaresch, R
    BLOOD, 2005, 106 (11) : 258B - 258B
  • [50] Impact of rituximab on outcome of autologous transplantation for mantle cell lymphoma.
    Naing, A.
    Palmer, J.
    Tsai, N.
    Kogut, N.
    Popplewell, L.
    Rodriguez, R.
    Krishnan, A.
    Nakamura, R.
    Forman, S. J.
    Nademanee, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 435S - 435S
12345